Technology

Jaguar Health

$3.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.13 (+4.18%) Today
+$0.06 (+1.85%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Jaguar Health and other stocks, options, and ETFs commission-free!

About JAGX

Jaguar Health, Inc. Common Stock, also called Jaguar Health, is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. Its products include Canalevia, Equilevia, and Neonorm. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment commercializes prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA. The listed name for JAGX is Jaguar Health, Inc. Common Stock.

CEO
Lisa A. Conte
Employees
29
Headquarters
San Francisco, California
Founded
2013
Market Cap
393.36M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
66.43M
High Today
$3.44
Low Today
$3.06
Open Price
$3.14
Volume
25.14M
52 Week High
$4.47
52 Week Low
$0.185

Collections

JAGX Earnings

-$9.09
-$6.06
-$3.03
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Apr 5, Pre-Market

You May Also Like

PRAA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure